GDNF: Back to the Clinic
Professor Steven Gill
Tuesday, 05 May 2015, 4pm to 5pm
Library, Sherrington Building, Department of Physiology, Anatomy and Genetics (DPAG), Parks Road, Oxford OX1 3PT (Please note that the front door closes at 4).
If you have a question about this talk, please contact Melanie Witt.
Professor Steven Gill pioneered the original work using Glial cell line-Derived Neurotrophic Factor (GDNF) in people with Parkinson’s. Since the initial pilot study, he has designed a new delivery system to enable this key growth factor to be delivered optimally, not only in terms of safety and efficacy, but also in a way which can be administered to patients practically and accurately.
Professor Gill’s Functional Neurosurgery Research Group has extensive pre-clinical and clinical Convection-enhanced delivery (CED) research experience and has successfully completed a number of studies which have led directly to clinical trials. This group has unique and world-leading CED catheter technology which is currently being used to treat patients with a range of neurological disorders including adults and children with malignant brain tumours and Parkinson’s Disease.
Topics: Parkinson’s disease—Surgery, Parkinson’s disease
Organisers: Melanie Witt (University of Oxford, Department of Earth Sciences, Department of Physiology Anatomy and Genetics)
Contact email: email@example.com
Audience: Members of the University only
Booking: Not required